Subsequent studies have identified CHCHD10 mutations in European populations in association with a variety of phenotypes, mostly ALS and FTD [21,22,23,24,25], but also Charcot–Marie–Tooth disease type 2 (CMT2) [26,27], spinal motor neuronopathy [28], motor neuron disease [21], and mitochondrial myopathy patients [29]. The gene discussed is CHCHD10; the disease is amyotrophic lateral sclerosis.